Rekha Hemrajani

Rekha Hemrajani

Direktor/Vorstandsmitglied bei MAXCYTE, INC.

Vermögen: 127 614 $ am 31.05.2024

54 Jahre
Health Technology
Consumer Services
Finance

Ursprung des Netzwerks ersten Grades von Rekha Hemrajani

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 36
23
Subsidiary Pharmaceuticals: Major 23
Public Company Biotechnology 23
Public Company Pharmaceuticals: Major 22
Public Company Biotechnology 21
Private Company Financial Conglomerates 9
Public Company Pharmaceuticals: Major 7
Public Company Biotechnology 6
5
Holding Company Biotechnology 5
Public Company Biotechnology 5
3
Subsidiary Pharmaceuticals: Major 3
2
Subsidiary Pharmaceuticals: Major 2
Public Company Pharmaceuticals: Major 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Rekha Hemrajani

UnternehmenSektorVerknüpfte PersonenHauptposition
University of California, Berkeley College/University

Robert J. Adelman

Corey Goodman

Mitchell Finer

Richard Douglas

Jaume Pons

Jason V. Coloma

Jennifer Cheng

Graham Walmsley

Lori Friedman

Hong I. Wan

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Biotechnology

Srini Akkaraju Akkaraju

Perry Karsen

J. Garland

Dan Spiegelman

Steve Kelsey

Pamela Klein

Patrick Haley

Jennifer Cheng

Lori Friedman

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Treasurer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Dov Goldstein

Srini Akkaraju Akkaraju

Alan Garber

Dan Spiegelman

Wendell Wierenga

Peter García

Corey Goodman

Vijay Pande

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Wendell Wierenga

William Ringo

Corey Goodman

Jaume Pons

Sophia Randolph

Hong I. Wan

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Director/Board Member

College/University

Alan Garber

Mitchell Finer

Mark Lupher

Sophia Randolph

Hong I. Wan

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Pablo Cagnoni

Perry Karsen

Carl Feldbaum

Thomas Wiggans

Doug Doerfler

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Director/Board Member

Investment Managers

Srini Akkaraju Akkaraju

Perry Karsen

Dan Spiegelman

Richard D. van Doren

Cory Freedland

Founder

Consultant / Advisor

Private Equity Investor

Director of Finance/CFO

Private Equity Investor

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Perry Karsen

Kimberly Manhard

Michael Giordano

Linda Kozick

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

University of California, Los Angeles College/University

Glen Y. Sato

Peter García

Michael Chang

Bill Tan

Graduate Degree

Masters Business Admin

Doctorate Degree

Undergraduate Degree

Kellogg School of Management College/University

Perry Karsen

Patrick Balthrop

Douglas Swirsky

Cory Freedland

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

OLEMA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Francis McCormick

J. Garland

Pamela Klein

Graham Walmsley

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

Director/Board Member

Investment Managers

Srini Akkaraju Akkaraju

Jay Shepard

William Ringo

Cory Freedland

Private Equity Investor

Corporate Officer/Principal

Private Equity Investor

Private Equity Investor

AMGEN INC. Pharmaceuticals: Major

David J. Scott

J. Garland

Peter García

Christopher J. DeRespino

General Counsel

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

University of Cambridge College/University

Francis McCormick

Eric Carter

Mohammed Malik

Yasir Al-Wakeel

Doctorate Degree

Doctorate Degree

Doctorate Degree

Graduate Degree

SANGAMO THERAPEUTICS, INC. Biotechnology

William Ringo

Thomas Wiggans

Paul Cleveland

Chairman

Director/Board Member

Director/Board Member

Investment Managers

Pablo Cagnoni

Mitchell Finer

Jim Scopa

Corporate Officer/Principal

Private Equity Investor

Private Equity Investor

Miscellaneous Commercial Services

Dan Spiegelman

Paul Cleveland

Laurent Fischer

Director/Board Member

Director/Board Member

Chief Executive Officer

ALDER BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Eric Carter

Paul Cleveland

James Bucher

Chief Tech/Sci/R&D Officer

Chief Executive Officer

General Counsel

Massachusetts Institute of Technology College/University

Vijay Pande

Angela Thedinga

Lisa Moore

Doctorate Degree

Graduate Degree

Doctorate Degree

College/University

Perry Karsen

Patrick Haley

Eric Matthews

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Medical Specialties

Perry Karsen

Art Mandell

Maher Masoud

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

NOVAVAX, INC. Biotechnology

Richard Rodgers

Stanley Erck

Richard Douglas

Director/Board Member

Chief Executive Officer

Director/Board Member

RELYPSA INC Pharmaceuticals: Major

J. Garland

Dan Spiegelman

Jay Shepard

President

Chairman

Founder

HERON THERAPEUTICS, INC. Biotechnology

Kimberly Manhard

Paul Goddard

Robert Hoffman

Director/Board Member

Chairman

Director of Finance/CFO

ELI LILLY AND COMPANY Pharmaceuticals: Major

Kimberly Manhard

William Ringo

Thomas Wiggans

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Jack Nielsen

Jason Lettmann

Jaume Pons

Director/Board Member

Director/Board Member

Founder

Biotechnology

Corey Goodman

Jaume Pons

Hong I. Wan

Director/Board Member

Director/Board Member

Founder

ARYX THERAPEUTICS, INC. Pharmaceuticals: Major

Jason Barker

Paul Goddard

Robert J. Adelman

Director of Finance/CFO

Chairman

Director/Board Member

Biotechnology

Pablo Cagnoni

Dan Spiegelman

Shelly Pinto

Chief Executive Officer

Chairman

Director of Finance/CFO

Medical/Nursing Services

Srini Akkaraju Akkaraju

Perry Karsen

Richard D. van Doren

Director/Board Member

Chairman

Director of Finance/CFO

Biotechnology

Robert J. Adelman

Corey Goodman

Michael Chang

Corporate Officer/Principal

Founder

Corporate Officer/Principal

University of Michigan College/University

Antonio J. Grillo-López

Richard Douglas

Sophia Randolph

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

ALLERGAN, INC. Pharmaceuticals: Major

Scott Whitcup

Eric Carter

Bill Tan

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

The Johns Hopkins University College/University

Michael Giordano

James Brady

Christopher J. DeRespino

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

Investment Managers

Jason Lettmann

Jaume Pons

Hong I. Wan

Private Equity Investor

Consultant / Advisor

Consultant / Advisor

Investment Managers

Robert J. Adelman

Corey Goodman

Jaume Pons

Founder

Founder

Private Equity Investor

General Government

Scott Whitcup

Reed Tuckson

Michael Giordano

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

University of San Francisco College/University

Richard D. van Doren

Jason V. Coloma

Dena House

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Stanford Graduate School of Business College/University

Alan Garber

Dan Spiegelman

Corporate Officer/Principal

Masters Business Admin

IOMAI CORPORATION Biotechnology

Stanley Erck

Richard Douglas

Chief Executive Officer

Director/Board Member

Theia Therapeutics, Inc.

Srini Akkaraju Akkaraju

Richard D. van Doren

Director/Board Member

Director of Finance/CFO

Investment Managers

Jack Nielsen

Cory Freedland

Corporate Officer/Principal

Corporate Officer/Principal

GSK PLC Pharmaceuticals: Major

Eric Carter

George Poste

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

College/University

Scott Whitcup

Chris Byrd

Corporate Officer/Principal

Doctorate Degree

Miscellaneous Commercial Services

Francis McCormick

Corey Goodman

Corporate Officer/Principal

Corporate Officer/Principal

CTI BIOPHARMA CORP. Pharmaceuticals: Major

Laurent Fischer

Reed Tuckson

Chairman

Director/Board Member

College/University

Scott Whitcup

David Sandoval

Undergraduate Degree

Undergraduate Degree

Statistik

International

Vereinigte Staaten 47
Vereinigtes Königreich 3
Irland 2
Italien 2

Sektoral

Health Technology 25
Consumer Services 14
Finance 8
Commercial Services 4
Health Services 2

Operativ

Director/Board Member 657
Corporate Officer/Principal 270
Independent Dir/Board Member 228
Chairman 117
Undergraduate Degree 84
  1. Börse
  2. Insiders
  3. Rekha Hemrajani
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT